Author Archives: medcon

Implementing Data Usage Reports

We introduced the concept of Data Usage Reports a year ago. Posting prototypes to officials unannounced led to a DH commitment for HSCIC to look at a roadmap for implementation.

3 weeks later, NHS England announced that they had done no work on implementing the care.data consent codes, and so transparency took a back seat to consent for most of the year. Not forgotten, not less important, just less urgent. Given that HSCIC only had 2 full time people working on either issue, this priority was clearly correct (although the hordes of staff digging care.data in deeper suggested a political allocation of resources).

As HSCIC moves towards an announcement on consent implementation in the new year (we have sent them some questions), it’s time to look at what we’ve learnt in a year of discussions about Data Usage Reports. Most of it is relatively dense detail, but the final section is the one missing piece.


It is necessary to close the Data Trust Deficit. The last year of work on Data Usage Reports, looking at all the details, shows this is entirely achievable, where there is political will.

Restating the Principle

You should have a complete knowledge of how individual level data about you has been used or disseminated. Any individual should be able to freely read the outcomes of those projects, the new research, the new knowledge, that they contributed to creating.

It’s that simple.
Continue reading

Electronic Health Records and Sharing along care pathways for direct care

 

The most important aspect of digital medical records is data flows along care pathways.  Despite all the political interest in care.data, and in secondary uses more widely, it is vital that clinically relevant medical information flows along care pathways where patients have not objected. It must be done consensually, safely, and transparently – and while the first two aspects of that considered in current implementations, they generally get stuck because there is no transparency in the system. Individual patient transparency should come via a data usage report, but that does not give the system an overarching view.

A systematic solution to transparency of the use of EHRs

For every organisation (or pathway, as relevant) that makes use of EHRs, there should be two figures added to NHS Choices:

  • % of inbound patients that receive records via EHR
  • % of outbound patients where records are sent via EHR

mockupCreated automatically off care provider systems, this should give a measure of how widely EHR transfer is used, rather than how often it could be used.
While a data usage report will tell an individual patient where their data has been used, this shows patients the level at which organisations are handing data off as patients move along care pathways.

       

medconfidential’s BMJ rapid response to “Slow and costly access to anonymised patient data impedes academic research”

Research is vital, and it is always unfortunate when any research project fails to deliver the promise in the funding proposal, irrespective of the reason. But railing against the custodian of the nation’s medical histories (BMJ 2015;351:h5087), the HSCIC, seems an odd choice if given any consideration.

The author’s institution was unable to give the assurances required that they were capable of looking after the data to the standard that the public expects. The standards have barely changed; what’s changed is that HSCIC has started checking the assurances more carefully – something it should have been doing all along.

Those necessary assurances are steered and delivered by institutions and supervisors on behalf of their students, not individual students themselves. It is not the students’ fault if their institution refuses to assure that it will take due care of 1 billion health events. And it is precisely the lack of verification of such assurances that sent 25 years of medical records to insurers, to marketers, and elsewhere.

Academia emerged with its reputation pretty much unscathed from the data debacles of 2014 and 2015. The high standards legitimate institutions expect of their researchers are one of the factors that justify the access to sensitive medical data, sometimes without consent, that academia is in a position to receive. Complaining that the standards are too high for your institution to agree to meet says more about the institution than the standards.

All research is important, but no single project – and no one institution – is more important than public confidence in all research. That is why a wide range of organisations support the “one strike principle for abuse or misuse of medical records. With the Hospital Episode Statistics, i.e. linked, longitudinal medical records of the population for the past 30 years, every woman with 3 children is uniquely identifiable – and with 2 children that’s about 90% likely (quite literally, a birthday attack).

In the last week, the ICO has fined the UK’s largest internet pharmacy for selling NHS patient and customer details to spammers, quacks and charlatans, pushing “innovative treatments and lottery scams (paragraphs 49, 51, 52). Those participating in the abuse of these records stand to make a great deal of money, and until there is a ban on marketing to patients that leads to jail time for these predators, there will continue to have to be deep scrutiny of every project, and every release.

The “promotion of health”, as undefined in the Care Act 2014, is a loophole so broad you could slip a Saatchi advertising hoarding through it, quacking.

The author’s experience is unfortunate. Both the researcher and their funder deserve a clear answer as to why their institution doesn’t provide them the infrastructure necessary for modern data-driven health research. But corners cannot be cut if patient confidence is to be maintained.

The care.data debacle includes lessons for many. While BMJ readers would always uphold the highest standards of Information Governance, readers may consider (former) colleagues who might – in similar or related circumstances – find themselves with a highly-cited paper, for all the wrong reasons?

HSCIC is the custodian of the nation’s medical histories. In making it available for legitimate research, it simply requires you fill in a form honestly. That shouldn’t be too high a bar*.

* Paragraph 62

-ENDS-

Excerpt from our last newsletter on the Saatchi/CHH bill:

medConfidential had some questions for Mr Heaton-Harris on the content of the draft Bill, and had a meeting with him last week. Our comments and suggestions arising from that meeting covered a ban on marketing to patientsData Usage Reports (including our example of what one might look like) and an alternative approach that might deliver the policy intent of the Bill without creating another new database, or giving DH duplicates of powers it already has.

 

[PRESS RELEASE] UK’s largest online pharmacy fined £130,000 for selling patients’ data to scammers

The Information Commissioner’s Office will this morning issue a £130,000 fine [1] to the UK’s largest NHS-approved online pharmacy, Pharmacy2U, [2] whose senior executives approved the sale of NHS patients’ and P2U customers’ personal data by direct marketers.

The ICO determined that, through a direct marketing company called Alchemy Direct Media (UK) Ltd, Pharmacy2U executives unlawfully and unfairly sold the personal data of over 21,000 NHS patients and P2U customers either directly, or through intermediaries, to:

  • Australian Lottery fraudsters [3] targeting male pensioners who were more likely to have chronic health conditions, or cognitive impairments;
  • a Jersey-based ‘healthcare supplement’ company [4] which the Advertising Standards Authority ruled against for “misleading advertising” and “unauthorised health claims”;
  • and a UK charity which used the details to solicit donations [5] for people with learning disabilities.

The ICO determined that the sale of personal data was “likely to cause substantial damage or substantial distress to the affected individuals”, [6] that the incidents were neither “one-off events or attributable to mere human error” [7] and that Pharmacy2U executives were negligent [8].

Phil Booth, coordinator of medConfidential said:

“When medConfidential made a complaint to the Information Commissioner on behalf of patients who were being marketed, we’d no idea the trade in their data was as murky as this.

“Vulnerable people shouldn’t be exposed to this sort of harm and distress, but what’s doubly appalling is that this was done by the largest NHS-approved online pharmacy in the country, which is part-owned by the company that provides a majority of GPs with their medical records systems.

“The Government has to act decisively. Six-figure fines alone won’t stamp out this poisonous trade; not when there’s so much profit to be made. There must now be a blanket, statutory ban on all marketing to patients.


“Those who profiteer from patients’ data are predators and should face prison when they are caught.”

Notes for editors:

  1. The fine is a ‘Monetary Penalty Notice’; the ICO’s full judgement is published here: https://ico.org.uk/action-weve-taken/enforcement/pharmacy2u-ltd/
  2. Following a Daily Mail investigation, first reported on 31 March 2015: http://www.dailymail.co.uk/news/article-3020480/Your-secrets-sale-NHS-dock-s-revealed-details-patients-bought-prescriptions-online-sold-off.html Pharmacy2U is 20% owned by EMIS, the single largest provider of GP IT systems across England, see p80: https://www.emisgroupplc.com/media/1084/emis-group-plc-annual-report-and-accounts-2014.pdf and EMIS’ current Chief Executive is also a Director of Pharmacy2U: https://www.companiesintheuk.co.uk/director/11692582/christopher-spencer
  3. See paragraphs 24-28 of the ICO’s judgement, which includes: “The National Trading Standards Scams Team has also informed the Commissioner’s office that the lottery company is the subject of an ongoing international criminal investigation into fraud and money laundering, although this wouldn’t have been known to Pharmacy2U.”
  4. See paragraphs 20-23, which includes: “In February 2015, the Advertising Standards Authority (“ASA”) issued an adjudication on Healthy Marketing Ltd in relation to breaches of the CAP Code, although this wouldn’t have been known to Pharmacy2U at the time the order was approved. The breaches related to a press advert which was found to contain misleading advertising and unauthorised health claims.”
  5. Paragraph 29 of the ICO’s judgement.
  6. Paragraph 65 of the ICO’s judgement.
  7. Paragraph 72 of the ICO’s judgement.
  8. Paragraph 63:  “The senior executive of Pharmacy2U must have known that there was a risk that people may object to the sale of data to the lottery company because, when he was asked to approve the order, he replied “OK but let’s use the less spammy creative please, and if we get any complaints I would like to stop this immediately”. However, he still approved the order.”

medConfidential campaigns for confidentiality and consent in health and social care, seeking to ensure that every flow of data into, across and out of the NHS and care system is consensual, safe and transparent. Founded in January 2013, medConfidential is an independent, non-partisan organisation working with patients and medics, service users and care professionals.

For further information or for immediate or future interview, please contact Phil Booth, coordinator of medConfidential, on 07974 230 839 or phil@medconfidential.org

– ends –

“Fair Processing” and the ICO

In practice, the ICO has a very simple test for fair processing:

Do data subjects know (i.e. have they been they fairly informed) what (processing of their data) you’re intending to do?

That’s it – is the organisation being completely honest?

If yes, that’s fair processing.

If no, that’s not “fair processing”.

It’s that simple. It’s not a high bar, and it’s not a complex bar.

If you end up in trouble, it’s because of surprises – you weren’t completely honest with the data subjects about what you were going to do.

With regard to fair processing, the ICO doesn’t make a distinction as to whether or not you should do something; it solely looks at whether you said you would. The ICO is often seen as facilitating data flows, because this test isn’t what people often seem to think it is.

The ICO considers itself to have one job in this regard, defined by the Data Protection Act, and that human rights are the remit of a Court. If someone is honest and informs you about using your data to breach your human rights, the ICO believes this is not a consideration for the data protection authorities. This may be an incomplete or incorrect reading of the law, but the current ICO has made its consideration.

In many controversial cases, organisations themselves – including the Government, Ministers, the NHS – all add additional requirements. These are not data protection constraints, they are moral constraints, they’re other legal constraints or they’re ‘ministerial gifts’ (e.g. the care.data opt out).

Remember, it’s only fair processing so long as what you tell people you’ll do matches what you actually do. (You can tell them you’ll do something and not do it – that’s still fair processing.)

When you want to do something new with data, if that wasn’t in the old rules, you need to tell people about the new rules. It is here that NHS England’s various data grabs have run into trouble, mainly because they don’t want to tell people quite what it is they want to do.

So in short, be completely honest.

No wonder the political machinations in the Department of Health and NHS England keep screwing it up…

P.S. Complaints about “fair processing” basically boil down to, “we don’t want to be honest with you”. Any fines simply show that you weren’t honest; one reason organisations get fined for losing data is because they’ve said that they won’t. If they didn’t say that, then losing your data mightn’t be a breach in those terms – but then no-one would do business with them. Which is why such promises get made in the first place.

[PRESS RELEASE] Kelsey leaves England for down under

medConfidential joins others in recognising the effect Tim Kelsey – Director for Patients and Information at NHS England, Chair of DH’s National Information Board, SRO for care.data and Chair of the care.data Programme Board – has had on the NHS.

Mr Kelsey announced today [1] that he will be resigning from NHS England and leaving the UK for Australia, to work as a commercial director for Telstra Health, a division of Australian telecommunications provider Telstra Corp – which in March this year acquired Dr Foster Intelligence [2], the company Mr Kelsey co-founded in 2000.

Tim’s commitment to the NHS is exemplified by serving his full notice period of 6 months. Earlier this morning, the HSCIC published its Board’s rejection of the Directions for the care.data pathfinders [3], a decision made in July.

Phil Booth, privacy advocate and long-standing scrutineer of Tim’s work, said:

“Tim’s gone back to his old job in the private sector, but serious questions of consent and transparency in NHS England remain unresolved. At the beginning of September Jeremy Hunt announced that responsibility for effective patient consent, long ignored by NHS England under Tim’s rule, had been handed to Dame Fiona Caldicott for resolution.

“We look forward to seeing how public confidence in the handling of NHS patient data will recover under new leadership. NHS England’s strident insistence on commercial re-use of medical records must now be reconsidered.

“Lord Saatchi’s Medical Database Bill, due to be re-published in the Commons the week after Conservative Party Conference, may provide some sign whether Jeremy Hunt has learnt the lessons of care.data for the entire NHS.”

Notes to editors:

1) NHS England announcement of Tim Kelsey’s resignation, 17/9/15: http://www.england.nhs.uk/2015/09/17/tim-kelsey-to-leave/

2) Telstra Health acquires Dr Foster Intelligence, 26/1/15: http://www.drfoster.com/updates/news/dr-foster-acquired-by-telstra-health/
Dr Foster Intelligence was formed when the Department of Health a 50% stake in Dr Foster in 2006, in a deal that was later criticised by the National Audit Office: http://www.nao.org.uk/report/dr-foster-intelligence-a-joint-venture-between-the-information-centre-and-dr-foster-llp/

3) Minutes of HSCIC Board meeting on 15/7/15, published on 17 September 2015, as part of papers for upcoming HSCIC Board meeting on 23/9/15. HSCIC reject the care.data Directions (previously approved by the care.data Programme Board and NHS England Board) for reasons listed on p10 of 300:

https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/461371/20150923_HSCICBoardpapers_Part1.pdf

medConfidential campaigns for confidentiality and consent in health and social care, seeking to ensure that every flow of data into, across and out of the NHS and care system is consensual, safe and transparent. Founded in January 2013, medConfidential is an independent, non-partisan organisation working with patients and medics, service users and care professionals.

For further information or for immediate or future interview, please contact Phil Booth, coordinator of medConfidential, on phil@medconfidential.org

– ends –

Simon Says: Walk

NHS England and Rewired State recently ran a competition with a £30k prize fund for apps around obesity

We didn’t win a prize (they get announced next week), but http://simonsayswalk.com/ was our submission. 

“I know I should really go for a walk 3 times a week, but I’m just too busy…”

‘Middle-aged, managerial-class, overweight white man’ – let’s call him ‘David’ – knows he’s at risk of health complications from being overweight, he just doesn’t do anything about it for a host of legitimate reasons; he has meetings… he has dinners… he has an important job that puts many constraints on his time… he has a family with caring responsibilities…  (While we use a male example above, SimonSays:Walk is gender-indifferent)

This is not primarily an information problem amongst those who, over time, are likely to make disproportionate use of NHS services. SimonSays:Walk is designed to help people make a commitment; to schedule time to go for a walk.

Quite simply, SimonSays:Walk provides a ‘button’ people can press to add such a commitment to the calendar / electronic diary they already use (or which their personal assistant manages for them) on their smartphone, PC or tablet. Having made such a commitment, by reminding them and providing them with a simple map, SimonSays:Walk assists someone to get into the habit of taking regular walks.

The regular dates begin after a delayed start: the first appointment to walk will be scheduled two weeks ahead of the point at which someone first chooses to make a commitment. This will help make the decision to commit a bit easier – a decision with consequences two weeks in the future may be easier to make than one that imposes more immediate demands (this is, of course, testable) – and should help ease any diary issues / conflicts. It is also logical, on the basis that if someone decided to go for a walk today, a diary app wouldn’t be particularly helpful!

The use of the person’s existing electronic diary means appointments can be moved if necessary, and means that other people (e.g. personal assistant) with access to the person’s dairy can take account of other considerations and, hopefully, assist the individual to pick up the habit.

SimonSays:Walk is also ‘infinitely forgiving’; if you didn’t go for a walk today, there’s no shame other than that you impose on yourself – you can just go next time. (Someone else with access to your diary may be less forgiving, however!)

SimonSays:Walk does not aim to solve the whole problem of obesity; different people need different things. This tool is designed for those who are busy, and who use some form of electronic diary – though one need not necessarily be busy to make use of it.

In terms of functionality, if you are within a mile or so of an NHS pharmacy – which SimonSays:Walk  determines using open data from the NHS via data.gov.uk – it will suggest you may want to walk past it. We chose this particular function for a number of reasons: firstly, because NHS pharmacies tend to already have helpful information on display in their street-facing windows; and secondly, because those windows offer a low cost way to provide positive reinforcement for individuals who have engaged with the app, and also to promote (the goal of) SimonSaysWalk and the benefits of regular physical exercise more generally.

If the person is not that close to a pharmacy, there are probably nicer walks available. SimonSays:Walk suggests a direction and ‘walk radius’, not a specific route. Suggesting people walk through an industrial estate might not be sensible, or wise. In any case, it better for individuals – who are likely to know their immediate area better than an online tool – to make those decisions for themselves.

The simple premise of SimonSays:Walk is that it matters far less where you are, and exactly where you walk, than that you are sitting in a chair all day long. Any walk is better than no walk; this is about making it happen. When it’s in your diary that you use every day, you can make a commitment that it actually happens.

SimonSays:Walk adopts a privacy-preserving model – and using information and processes that people already use day-to-day – and tries to work with people’s lives, rather than trying to impose a major life change on them.

Once people become used to walking regularly, non-confidential phone calls, etc. could be done via mobile while going for a walk – or meetings could be scheduled about 25 minutes walk apart. We appreciate that in the UK, this would probably work better in the summer months.

If there is no GPS information available, e.g. from a non-location aware desktop browser, the map is centered on the pavement East of the Cenotaph, with a generic message about a walk.

People already have plenty of information that being overweight is bad for them; this is a tool to help them do something about it.

 

http://simonsayswalk.com/

Beach reading from medConfidential: a mid-August update

No newsletter this month, so we thought we’d do a quick round-up on the blog of some things you may wish to read, “chillaxing” on a beach.

What difference does 10% make?

Dribs and drabs of information about care.data are beginning to leak out. Many may have missed the Minister for care.data, George Freeman MP, give a very carefully couched answer to Parliament about the number of patients who have opted out.

As you may recall, the last time anyone said anything to Parliament directly was when Kingsley Manning suggested “about a hundred” patients have been affected by NHS England’s ‘Type 2’ cockup. His follow-up written answer “actually it’s more like 700,000” was somewhat buried by being published in the run-up to the Election.

Mr Freeman, however, had the more difficult task of announcing a much bigger number – which he did by the time-honoured tradition of hiding behind percentages and ranges. Even so, his answer meant we had to update our own estimate to between 950,000 and 1.6 million.

We had increased our estimate based on an extraordinarily detailed series of FOI requests by Dr Neil Bhatia, which he very kindly shared with us (and others). Dr Bhatia’s figures showed that – while what Mr Freeman told Parliament was true in as far as it went – the picture was somewhat more complex, possibly even alarming.

Mr Freeman limited his comments to a range which he said “the majority fall between 0.5 – 2.5%” opt outs. Dr Bhatia’s figures show quite a number of practices with opt outs in the 4 – 6% range, running as high as 12% or even 14% in a handful of practices. And don’t forget, these are the pathfinders – the volunteers, the supposedly keen practices. No one has detailed figures from any urban areas yet, as NHS England is still struggling to recruit practices in Leeds.

 

Talking more about care.data (not just on a beach)

One thing that does need to massively improve is the way that care.data is talked about.

NHS England is still far too fond of hiding its dodgy commercial re-use ambitions behind the figleaf of research. At the recent “son of care.data” events – officially, NIB ‘Work Stream’ 2.2 – the only secondary use that NHS England really wanted to talk about was research; offering very little to those asking “What about the other uses?”, such as commissioning.

If you happen to be planning a discussion of care.data after the holidays, here are some thoughts we hope are useful.

There are some sensible discussions going on, and a number of positive developments we hope will be announced in the months immediately following the summer – not least HSCIC’s ‘fix’ for the yet-to-be honoured ‘Type 2’ (9Nu4) opt outs. There are several legal instruments in the pipeline: new Directions for the care.data pathfinders and patient objections; CAG Regulations establishing promised safeguards and sanctions, and closing “the promotion of health” loophole; and hopefully, “at the earliest opportunity”, primary legislation to put the National Data Guardian on a statutory footing.

Let’s hope NHS England reflects over the summer on how little its ‘head down, keep people in the dark and keep rolling at all costs’ approach has achieved over the past 18 months – except further eroding public trust – and starts meeting some of the many promises it has made.

 

NHS Improvement

You may have missed the quiet announcement, just before Jeremy Hunt went off on his holidays, that DH’s troubled arm’s-length body, Monitor, and the NHS “Trust Development Agency” (that’s Trust as in NHS Trusts) are to merge, under the new brand “NHS Improvement”.

When it comes to Monitor’s worldview on data, things can only get better; it seems to have been taking care.data as a handbook, rather than as a salutary lesson. So the new NHS Improvement may provide a springboard for a huge leap forward. Or backwards, depending on crucial choices that must be made. Will they follow NHS England’s past-its-sell-by-date worldview, or the best thinking and actions of the reformed and reforming HSCIC – and what about patients? We’ve pondered the potential

Beyond this new merger, there are other areas that could be improved – not least the introduction of a data incident protocol aiming to provide patients in data crises with knowledge rather than media management, and to aspire to something more ethical than mere DPA-compliance. Also better consensual, safe and transparent sharing of medical records along care pathways, for patients’ direct care.

 

Use of data

With regard to the proper use of patient data, we’re still awaiting more details of what the high street pharmacies are looking to do with the Summary Care Record. Three were asked, two denied they were planning to abuse it. And our ‘old friends’ at PA Consulting have come out in their defence. (You may remember PA Consulting as the ones who made money uploading 25 years’-worth of our hospital data to Google, not to mention previous financial benefits from servicing the old Home Office ID cards scheme.)

One bright idea in the run-up to the Election by someone who probably hoped they’d never be responsible for implementing it – think mistakes like the Poll Tax – was to use people’s medical histories to deny them benefits. As we’ve discovered, sometimes “high level” political ideas interact badly on the ground; we wrote to David Cameron recently about just such an initiative, done in his name.

The Government gave the ‘employment problem’ to an Independent Review Panel, which currently has a consultation out. If you have a free moment, you may wish to respond to Question 7 (amongst others).

medConfidential is concerned that as DWP and HMRC are reengineered over the next 5 years, there’ll not only be more and more temptation, but a now practical ability to do similar things.

We would like to think that DWP and HMRC will take a decision that someone in the NHS is capable, though it seems to refuse to accept those same decisions when the professional outcome goes the other way. This type of discrepancy forms the basis for our draft submission to the Comprehensive Spending Review – if you have any comments, please e-mail them to coordinator@medconfidential.org

 

And finally…

In September, we’ll find out what happened when the deeply flawed Directions for the care.data pathfinders were considered by the HSCIC Board. If there were to be further delay, all the dates that NHS England has been announcing for the last month or more will have been misleading. Let’s hope NHS England didn’t screw anything up due to lack of consultation…

Phil’s on holiday for the next few weeks, so Sam’s really hoping NHS England doesn’t do anything catastrophically stupid before September. For that matter, NHS England probably is too…

 

We hope you enjoy your summer!
Sam and Phil

Welcoming NHS Improvement

The status quo of NHS  data collection could be described as “Collect it all yourself; trust no-one else”. This is clearly unsustainable: care.data may have been the straw that almost broke the camel’s back; the Prime Minister’s Challenge Fund just tossed some steel girders on top. Poor camel.

With the merger of the NHS Trust Development Authority (TDA) and Monitor under a new name, “NHS Improvement”, there may be an opportunity to begin to address some serious data shortcomings – and some persistent category errors. Monitor was supposed to act as a Government “stick”; the TDA was supposed to be an NHS “carrot” – but, as with so many bureaucracies, the left hand seemed not to know what the right hand was doing, so the stick ruled and very little productive got done.

From documents medConfidential has seen, Monitor’s approach to data seems to have adopted care.data as a handbook, rather than recognising the scheme for the “fiasco” it has so clearly become. Problems that emerged with the “pioneer” in Southend could have been as much down to flawed advice propagated by Monitor as it was the result of NHS England’s inadequate and inaccurate guidance.

We had expected the Government to have responded to its “Accredited Safe Havens” consultation from last summer by now. That it hasn’t speaks volumes. That some of the “pioneers” and “vanguards” reflect a backward-looking data worldview still prevalent in parts of DH gives cause for concern. It’s clearly not just care.data that’s infecting the thinking, and in real danger of further damaging patient – and professional – trust.

In the forthcoming consultation on the powers and remit of the National Data Guardian, we hope the Department gathers views on NDG having to be consulted on every use of NHS England’s and other statutory bodies’ powers to require data. While NHS Improvement should certainly not be given powers to require data (HSCIC doesn’t have such powers either), it could be a place where conversations can be had between the various stakeholders – care providers, commissioners and the Department of Health – about the statistics required to firstly measure, and then “improve” a particular area.

This should not be about measuring only what it is you want to manage, but be about measuring the things that matter. Not least because, as has been repeatedly been shown, simple measures can lead to detrimental care when ‘gamed’ by those in the system.

Learning the lessons of care.data – though some are still lagging behind – such datasets must always and exclusively be aggregated datasets; published statistics where not only the figures but the methodology are published for all to read. (Some datasets where the detail contains small numbers may need to remain unpublished, available only in a tightly-controlled safe setting.) The public must be able to see, and debate, the specification of any dataset that will be used for strategic decision making.

While the research process involved in the design and testing of these datasets may need access to consented individual-level data, such as should be possible with data in the new Secure Data Facility, the use of aggregated counts as the basis for decisions, rather than individual-level detail would remove many of the problems NHS England still claims will befall GP practices where 12% or more of the patients have already opted out of its ill-conceived, zombie data grab.

NHS Improvement could be a good place for these conversations to take place, if it steps up several gears. NHS England could even have a seat at the table – so long as NHS Improvement convenes and manages the process of defining these new aggregated measurement datasets, of which, given the dearth of them, there will probably need to be a fair few.

The process could be designed to ensure that care providers can have measures they feel accurately reflect good care, NHS England gets the evidence base it needs to justify decisions, and HSCIC can focus on the vital implementation issues – such as feasibility, assurance and process.

Preventing a repeat of the Prime Minister’s Challenge Fund debacle would appear to require such a venue; NHS England has proved itself institutionally incapable of being a trusted broker, and HSCIC has other roles. A correctly constituted NHS Improvement, appropriately staffed and resourced, could provide a venue to help ensure the outcome: “High quality care for all, now and for future generations”.

It could also help with another problem

In much the same way as the DWP requires health assessments by its own staff, rather than trusting the assessments of NHS care providers, and the way HMRC trusts nothing it didn’t confirm itself, an underlying cause of many problems in the NHS is quite easy to define: NHS bodies simply don’t trust other NHS bodies.

This is why bean counters in a CCG want detailed medical records of all “high cost” patients. Or indeed believe, in spite of Caldicott2, they should have access to individual-level medical records.

Multiple interlocking but discrete datasets, properly designed and produced as above, can show up the various “tricks” that get used to move people out of one column into another – “massaging” the figures – a practice that certainly should be measured. And acted upon by someone independent.

If an NHS organisation believes statistics being provided are fraudulent, then that’s a question for NHS Protect, rather than CCGs thinking they can investigate themselves. Integrity on process can be provided by HSCIC working on collation and process (SUS and GPES already do this for hospitals and GPs).

For NHS Improvement, ask the patients?

Though it has positive potential, NHS Improvement also has the potential to become yet another arcane and somewhat obscure NHS body. Yet one of the groups who understand a great deal about what might provide disproportionate improvements within the NHS are that chronically underrepresented group who use it every day; patients.

While NHS England continues to have its own political priorities and funding considerations, when HSCIC is telling patients what did actually happen to their data, patients can (also) feed back to NHS Improvement what they believe should have happened – a genuine partnership in improvement.

Consensual, Safe and Transparent Sharing of Medical Records Along Care Pathways

medConfidential notes the various calls for medical records for patients’ direct care to flow with patients along care pathways as a priority, following consent for treatment – and the new (or pending) legal requirement that the NHS number be the mandatory identifier.

Both of these are generating some levels of patient concern. However both can be implemented in a manner which enhances trust, rather than risking it further.

Reporting to HSCIC that a particular NHS number has entered an organisation for care, and whether this was via a ‘handover’ of electronic records or through some other means (e.g. non-electronic referral, for example from A&E – or if there was some form of electronic handover failure) would begin to assuage a range of concerns. HSCIC could also then publish aggregated statistics for each pair of providers, to show how the different types of record handoffs (successful, failed, or other-manual) had worked, with the aim of increasing successful handling of electronic records for direct care along a pathway.

For providers receiving data on a care pathway, a figure could be provided of the number or percentage of patients who had refused consent for their medical records to be handed across electronically to/from that provider, but who consented to care. There will be a range of issues around this, e.g. Mental Health records being restricted – and where there are ‘outliers’ for a particular provider or flow (either due to technical issues, or because of consent choices) these will need to be addressed through a transparent process.

For patients, HSCIC should then be able to report to each person individually, via their Personalised Data Usage Report, everywhere their NHS number (and associated data) has been passed. As patients can learn exactly what does happen to their records, and why – and that it is the norm for this to happen without incident – this will contribute to a tendency towards increasing trust around the handling of records.

This process should be systematic, automatic, accurate and, over time, complete.

Additionally, as the expectation becomes that records do flow, patients will be able to see where this flow hasn’t happened (in addition to potentially experiencing the effects) and can raise questions – which is entirely appropriate if, as is asserted, sharing of medical records along a care pathway for direct care will improve outcomes. It is far more important to patient care and safety to know and correct flows for direct care where they aren’t happening as they should, as it is to know the data and flows for secondary use.

We emphasise the distinction between direct care – in effect, data sharing with implied consent between medical professionals who interact with and provide treatment to a patient – and secondary uses, which cannot presume consent, and for which patients have a right to opt out.


To illustrate this with a recent example; there are very few reasons to dispute or object to medical records being used for direct (“integrated”) care in, say, a meeting held between and run by medical professionals with a duty of care for a particular patient with complex needs, to devise a specific care plan for that patient. But a secondary use of that same information would be a meeting run by an accountant looking ways to manage the impact of a “high cost” individual.

It is entirely up to the system to transparently describe and discuss the difference, and it is the public knowledge that this will be examined which helps keep the system honest. And therefore trustworthy.